Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.

Mines D, Hill D, Yu H, Novelli L.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):367-72.

PMID:
15883980
2.

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.

Rubino A, Roskell N, Tennis P, Mines D, Weich S, Andrews E.

BMJ. 2007 Feb 3;334(7587):242.

3.

Suicide risk and choice of antidepressant.

Davis A, Gilhooley M, Agius M, Zaman R.

Psychiatr Danub. 2010 Jun;22(2):358-9.

4.

Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, Vitiello B, Iyengar S, Birmaher B, Ryan ND, Zelazny J, Onorato M, Kennard B, Mayes TL, Debar LL, McCracken JT, Strober M, Suddath R, Leonard H, Porta G, Keller MB.

Am J Psychiatry. 2009 Apr;166(4):418-26. doi: 10.1176/appi.ajp.2008.08070976.

5.

Antidepressants and the risk of suicidal behaviors.

Jick H, Kaye JA, Jick SS.

JAMA. 2004 Jul 21;292(3):338-43.

PMID:
15265848
6.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
7.

Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?

Perlis RH, Uher R, Perroud N, Fava M.

J Clin Psychiatry. 2012 Nov;73(11):1439-42. doi: 10.4088/JCP.12m07777.

8.
9.
10.
11.

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.

Martinez C, Assimes TL, Mines D, Dell'aniello S, Suissa S.

BMJ. 2010 Feb 5;340:c249. doi: 10.1136/bmj.c249.

12.

Causal or casual?

Egberts TC.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):365-6. No abstract available.

PMID:
15924331
13.

Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.

De Nayer A, Geerts S, Ruelens L, Schittecatte M, De Bleeker E, Van Eeckhoutte I, Evrard JL, Linkowski P, Fossion P, Leyman S, Mignon A.

Int J Neuropsychopharmacol. 2002 Jun;5(2):115-20.

PMID:
12135535
14.

Economic appraisal of citalopram in the management of single-episode depression.

Sclar DA, Skaer TL, Robison LM, Galin RS.

J Clin Psychopharmacol. 1999 Oct;19(5 Suppl 1):47S-54S.

PMID:
10507508
15.

Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.

Tzanakaki M, Guazzelli M, Nimatoudis I, Zissis NP, Smeraldi E, Rizzo F.

Int Clin Psychopharmacol. 2000 Jan;15(1):29-34. Erratum in: Int Clin Psychopharmacol 2000 Mar;15(2):120.

PMID:
10836283
16.

The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.

Brent DA.

Depress Anxiety. 2009;26(10):871-4. doi: 10.1002/da.20617. No abstract available.

17.

Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database.

Coupland C, Hill T, Morriss R, Arthur A, Moore M, Hippisley-Cox J.

BMJ. 2015 Feb 18;350:h517. doi: 10.1136/bmj.h517.

18.

Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.

Schneeweiss S, Patrick AR, Solomon DH, Mehta J, Dormuth C, Miller M, Lee JC, Wang PS.

Arch Gen Psychiatry. 2010 May;67(5):497-506. doi: 10.1001/archgenpsychiatry.2010.39.

19.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT.

Biol Psychiatry. 2007 Dec 15;62(12):1371-9. Erratum in: Biol Psychiatry. 2012 Feb 15;71(4):387. Biol Psychiatry. 2008 Apr;63(7):721.

PMID:
17825800
20.

Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.

Wade AG, Saragoussi D, Despiégel N, François C, Guelfucci F, Toumi M.

Curr Med Res Opin. 2010 May;26(5):1161-70. doi: 10.1185/03007991003738519.

PMID:
20297951
Items per page

Supplemental Content

Support Center